Monthly Newsletter

LGC has announced the acquisition of Lipomed AG’s reference materials business including standards with drugs of abuse and toxicology applications, and thus greatly complementing LGC’s reference standards offering.

Lipomed Reference Standards is a leading manufacturer and supplier of analytical reference standards with ISO/IEC 17025 accreditations for testing and ISO 17034 accreditation for production of reference materials. The business currently has manufacturing operations in Switzerland and a sales and distribution base in Cambridge, MA, USA, and this transaction will add a range of innovative products which are marketed and distributed in more than 50 countries around the world.

Ken Yoon, Executive Vice President & General Manager, LGC Standards, said, “We are really excited to be bringing Lipomed’s innovative reference standards team into LGC. Their drugs of abuse and toxicology portfolio will be a great fit with the LGC Standards business unit. We look forward to combining Lipomed’s and LGC’s expertise to deliver excellent solutions for our customers and to continue our mission of delivering Science for a Safer World.”  

About LGC

LGC is a leading, global life science tools company, providing mission-critical components and solutions into high-growth application areas across the human healthcare and applied market segments. Its high-quality product portfolio is comprised of mission-critical tools for genomics and for quality assurance applications, which are typically embedded and recurring within its customers' products and workflows and are valued for their performance, quality and range.

LGC's tools play a key role in customer workflows from discovery applications through to commercial manufacture and enable its customers to: bring new diagnostics and therapies to market; progress research and development; optimise food production; and continuously monitor and enhance the quality of food, the environment and consumer products.

LGC's 180 years of scientific heritage, combined with a track record of innovation and value-enhancing acquisitions, has enabled the company to build its product portfolio and expertise, and develop deep relationships with customers, industry partners and the global scientific community.

LGC's core purpose of Science for a Safer World and its core values of passion, curiosity, integrity, brilliance and respect, drive its culture. As of 31 July 2022, it employs over 4,100 employees, of which 27% hold PhD and/or master's degrees.? Its products and services are delivered by highly qualified and experienced teams, operating from a global network of accredited sites that showcase its scientific and manufacturing capabilities.